{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:47:25Z","timestamp":1790063245012,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.kint.2016.12.022","type":"journal-article","created":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T04:46:25Z","timestamp":1488257185000},"page":"1347-1361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Murine recombinant angiotensin-converting enzyme 2 attenuates kidney injury in experimental\u00a0Alport syndrome"],"prefix":"10.1016","volume":"91","author":[{"given":"Eun Hui","family":"Bae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa R.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Konvalinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaibhav B.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin Y.","family":"Oudit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"York","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Scholey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2016.12.022_bib1","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/bmj.1.3454.504","article-title":"Hereditary familial congenital haemorrhagic nephritis","volume":"1","author":"Alport","year":"1927","journal-title":"Br Med J"},{"key":"10.1016\/j.kint.2016.12.022_bib2","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(88)90753-2","article-title":"Genetics of classic Alport's syndrome","volume":"2","author":"Flinter","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2016.12.022_bib3","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1681\/ASN.2012020148","article-title":"Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy","volume":"24","author":"Savige","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.12.022_bib4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/ki.2009.223","article-title":"Treatment of Alport syndrome: beyond animal models","volume":"76","author":"Gross","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.12.022_bib5","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0272-6386(99)70385-9","article-title":"ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy","volume":"34","author":"Remuzzi","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2016.12.022_bib6","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00467-012-2372-9","article-title":"Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndrome","volume":"28","author":"Webb","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2016.12.022_bib7","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1046\/j.1523-1755.2003.00779.x","article-title":"Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome","volume":"63","author":"Gross","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.12.022_bib8","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1093\/ndt\/gfh219","article-title":"Antifibrotic, nephroprotective potential of ACE inhibitor vs AT1 antagonist in a murine model of renal fibrosis","volume":"19","author":"Gross","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2016.12.022_bib9","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.ajpath.2015.01.021","article-title":"Characterization of the Intrarenal Renin-Angiotensin System in Experimental Alport Syndrome","volume":"185","author":"Bae","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.kint.2016.12.022_bib10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.yjmcc.2013.11.017","article-title":"Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE\/ADAM-17: a positive feedback mechanism in the RAS","volume":"66","author":"Patel","year":"2014","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.kint.2016.12.022_bib11","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.2353\/ajpath.2006.051091","article-title":"Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin ii-dependent glomerulosclerosis","volume":"168","author":"Oudit","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.kint.2016.12.022_bib12","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2353\/ajpath.2007.060977","article-title":"Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury","volume":"171","author":"Wong","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.kint.2016.12.022_bib13","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/01.HYP.0000259942.38108.20","article-title":"Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats","volume":"49","author":"Yamazato","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2016.12.022_bib14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-beta family signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.kint.2016.12.022_bib15","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1038\/sj.emboj.7601818","article-title":"TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA","volume":"26","author":"Lee","year":"2007","journal-title":"EMBO J"},{"key":"10.1016\/j.kint.2016.12.022_bib16","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri3495","article-title":"Mitogen-activated protein kinases in innate immunity","volume":"13","author":"Arthur","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.kint.2016.12.022_bib17","doi-asserted-by":"crossref","first-page":"24834","DOI":"10.1074\/jbc.M113.485326","article-title":"Determination of an angiotensin II-regulated proteome in primary human kidney cells by stable isotope labeling of amino acids in cell culture (SILAC)","volume":"288","author":"Konvalinka","year":"2013","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2016.12.022_bib18","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.semcdb.2008.09.004","article-title":"Regulation of the proteolytic disintegrin metalloproteinases, the 'Sheddases'","volume":"20","author":"Murphy","year":"2009","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.kint.2016.12.022_bib19","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.molcel.2010.01.034","article-title":"Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation","volume":"37","author":"Xu","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.kint.2016.12.022_bib20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrneph.2012.281","article-title":"Improving the efficacy of RAAS blockade in patients with chronic kidney disease","volume":"9","author":"Lambers Heerspink","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2016.12.022_bib21","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/ki.2011.381","article-title":"Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy","volume":"81","author":"Batlle","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.12.022_bib22","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s11906-014-0420-5","article-title":"ACE2: angiotensin II\/angiotensin-(1\u20137) balance in cardiac and renal injury","volume":"16","author":"Varagic","year":"2014","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.kint.2016.12.022_bib23","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/sj.ki.5000210","article-title":"RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney","volume":"69","author":"Sachetelli","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.12.022_bib24","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00467-011-1992-9","article-title":"Tubulointerstitial injury and the progression of chronic kidney disease","volume":"27","author":"Hodgkins","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2016.12.022_bib25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1053\/j.ackd.2005.07.011","article-title":"Progression in chronic kidney disease","volume":"12","author":"Eddy","year":"2005","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.kint.2016.12.022_bib26","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1046\/j.1523-1755.1999.00744.x","article-title":"Role for transforming growth factor-beta1 in alport renal disease progression","volume":"56","author":"Sayers","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.12.022_bib27","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0002-9440(10)64802-X","article-title":"Integrin alpha1beta1 and transforming growth factor-beta1 play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy","volume":"157","author":"Cosgrove","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.kint.2016.12.022_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ki.2010.373","article-title":"Bacterial CpG-DNA accelerates Alport glomerulosclerosis by inducing an M1 macrophage phenotype and tumor necrosis factor-alpha-mediated podocyte loss","volume":"79","author":"Ryu","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.12.022_bib29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/path.2979","article-title":"Tumour necrosis factor-alpha drives Alport glomerulosclerosis in mice by promoting podocyte apoptosis","volume":"226","author":"Ryu","year":"2012","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.kint.2016.12.022_bib30","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.humpath.2009.08.024","article-title":"Interstitial inflammation in Alport syndrome","volume":"41","author":"Jedlicka","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1016\/j.kint.2016.12.022_bib31","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/labinvest.3700715","article-title":"Lymphocytes are dispensable for glomerulonephritis but required for renal interstitial fibrosis in matrix defect-induced Alport renal disease","volume":"88","author":"LeBleu","year":"2008","journal-title":"Lab Invest"},{"key":"10.1016\/j.kint.2016.12.022_bib32","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s13238-010-0019-9","article-title":"MAPK signaling in inflammation-associated cancer development","volume":"1","author":"Huang","year":"2010","journal-title":"Protein Cell"},{"key":"10.1016\/j.kint.2016.12.022_bib33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cardiores.2007.04.007","article-title":"Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice","volume":"75","author":"Oudit GY KZ","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.kint.2016.12.022_bib34","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.trsl.2008.12.008","article-title":"Renin-angiotensin-aldosterone system-mediated redox effects in chronic kidney disease","volume":"153","author":"Nistala","year":"2009","journal-title":"Transl Res"},{"key":"10.1016\/j.kint.2016.12.022_bib35","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1681\/ASN.V115965","article-title":"Renal response to tissue injury: lessons from heme oxygenase-1 gene ablation and expression","volume":"11","author":"Agarwal","year":"2000","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.12.022_bib36","doi-asserted-by":"crossref","first-page":"F1846","DOI":"10.1152\/ajprenal.00265.2006","article-title":"Albumin overload induces adaptive responses in human proximal tubular cells through oxidative stress but not via angiotensin II type 1 receptor","volume":"292","author":"Shalamanova","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2016.12.022_bib37","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1210\/endo.143.8.8931","article-title":"High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells","volume":"143","author":"Hsieh","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.kint.2016.12.022_bib38","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/sj.ki.5002188","article-title":"Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice","volume":"71","author":"Brezniceanu","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.12.022_bib39","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/HYPERTENSIONAHA.110.164244","article-title":"Prevention of angiotensin II\u2013mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2","volume":"57","author":"Zhong","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2016.12.022_bib40","doi-asserted-by":"crossref","first-page":"C1318","DOI":"10.1152\/ajpcell.00036.2009","article-title":"Selective and specific regulation of ectodomain shedding of angiotensin-converting enzyme 2 by tumor necrosis factor alpha-converting enzyme","volume":"297","author":"Iwata","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.kint.2016.12.022_bib41","doi-asserted-by":"crossref","first-page":"e85958","DOI":"10.1371\/journal.pone.0085958","article-title":"Characterization of angiotensin-converting enzyme 2 ectodomain shedding from mouse proximal tubular cells","volume":"9","author":"Xiao","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2016.12.022_bib42","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/HYPERTENSIONAHA.114.03743","article-title":"Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin ii type i receptor\u2013dependent mechanism","volume":"64","author":"Deshotels","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2016.12.022_bib43","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1161\/01.RES.0000178789.16929.cf","article-title":"Combination of tumor necrosis factor-alpha ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice","volume":"97","author":"Kassiri","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2016.12.022_bib44","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1681\/ASN.2008050492","article-title":"Loss of TIMP3 enhances interstitial nephritis and fibrosis","volume":"20","author":"Kassiri","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.12.022_bib45","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0272-6386(87)80188-9","article-title":"Exogenous creatinine clearance accurately assesses filtration failure in rat experimental nephropathies","volume":"10","author":"Zager","year":"1987","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2016.12.022_bib46","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/ki.2009.501","article-title":"Major contribution of tubular secretion to creatinine clearance in mice","volume":"77","author":"Eisner","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.12.022_bib47","series-title":"Effects of Drugs on Clinical Laboratory Tests. 5th ed","author":"Young","year":"2000"},{"key":"10.1016\/j.kint.2016.12.022_bib48","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1172\/JCI39569","article-title":"Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome","volume":"120","author":"Tanaka","year":"2010","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2016.12.022_bib49","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1681\/ASN.2005101044","article-title":"Chronic renal failure and shortened lifespan in col4a3+\/- mice: an animal model for thin basement membrane nephropathy","volume":"17","author":"Beirowski","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.12.022_bib50","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1681\/ASN.2007070829","article-title":"Irradiation prolongs survival of alport mice","volume":"19","author":"Katayama","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.12.022_bib51","doi-asserted-by":"crossref","unstructured":"Wysocki J, Ye M, Khattab AM, et\u00a0al. Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy [e-pub ahead of print]. Kidney Int. http:\/\/dx.doi.org\/10.1016\/j.kint.2016.09.032.","DOI":"10.1016\/j.kint.2016.09.032"},{"key":"10.1016\/j.kint.2016.12.022_bib52","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.ajpath.2013.02.011","article-title":"Type VIII collagen mediates vessel wall remodeling after arterial injury and fibrous cap formation in atherosclerosis","volume":"182","author":"Lopes","year":"2013","journal-title":"Am J Pathol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253817300157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253817300157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T04:36:00Z","timestamp":1622608560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253817300157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0085253817300157"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2016.12.022","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Murine recombinant angiotensin-converting enzyme 2 attenuates kidney injury in experimental\u00a0Alport syndrome","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2016.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2016.09.032","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017, International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}